These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17676424)

  • 1. Nutritional treatment of cancer cachexia in rats. Use of a diet formulated with a crayfish enzymatic extract.
    Cremades O; Parrado J; Jover M; Collantes de Terán L; Gutiérrez JF; Bautista Palomas JD
    Eur J Nutr; 2007 Sep; 46(6):347-53. PubMed ID: 17676424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
    Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
    Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio of n6 to n-3 fatty acids in the diet affects tumor growth and cachexia in Walker 256 tumor-bearing rats.
    Pizato N; Bonatto S; Yamazaki RK; Aikawa J; Nogata C; Mund RC; Nunes EA; Piconcelli M; Naliwaiko K; Curi R; Calder PC; Fernandes LC
    Nutr Cancer; 2005; 53(2):194-201. PubMed ID: 16573380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
    Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M
    Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with N-3 polyunsaturated fatty acids for one generation.
    Togni V; Ota CC; Folador A; Júnior OT; Aikawa J; Yamazaki RK; Freitas FA; Longo R; Martins EF; Calder PC; Curi R; Fernandes LC
    Nutr Cancer; 2003; 46(1):52-8. PubMed ID: 12925304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.
    Fujitsuka N; Asakawa A; Uezono Y; Minami K; Yamaguchi T; Niijima A; Yada T; Maejima Y; Sedbazar U; Sakai T; Hattori T; Kase Y; Inui A
    Transl Psychiatry; 2011 Jul; 1(7):e23. PubMed ID: 22832525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
    Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
    Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cachexia.
    Tisdale MJ
    Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
    Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia.
    Saitoh M; Hatanaka M; Konishi M; Ishida J; Palus S; Ebner N; Döhner W; von Haehling S; Anker SD; Springer J
    Int J Cardiol; 2016 Sep; 218():312-317. PubMed ID: 27240157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acid supplements for cancer-associated weight loss.
    Jatoi A
    Nutr Clin Pract; 2005 Aug; 20(4):394-9. PubMed ID: 16207679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.
    Pappalardo G; Almeida A; Ravasco P
    Nutrition; 2015 Apr; 31(4):549-55. PubMed ID: 25770317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
    Olivan M; Busquets S; Figueras M; Fontes de Oliveira C; Toledo M; Sette A; Ventura da Silva P; Barberis P; Argilés JM; López-Soriano FJ
    Clin Nutr; 2011 Feb; 30(1):33-7. PubMed ID: 20655130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant effects of açaí seed ( Euterpe oleracea ) in anorexia-cachexia syndrome induced by Walker-256 tumor.
    Nascimento VH; Lima CD; Paixão JT; Freitas JJ; Kietzer KS
    Acta Cir Bras; 2016 Sep; 31(9):597-601. PubMed ID: 27737344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect.
    Beluzi M; Peres SB; Henriques FS; Sertié RA; Franco FO; Santos KB; Knobl P; Andreotti S; Shida CS; Neves RX; Farmer SR; Seelaender M; Lima FB; Batista ML
    PLoS One; 2015; 10(3):e0122660. PubMed ID: 25807446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia.
    Asp ML; Tian M; Kliewer KL; Belury MA
    Cancer Biol Ther; 2011 Dec; 12(11):957-65. PubMed ID: 22104958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 Fatty Acids in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments.
    Garcia JM; Shamliyan TA
    Am J Med; 2017 Oct; 130(10):1151-1155. PubMed ID: 29016347
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
    Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
    Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent development in research and management of cancer anorexia-cachexia syndrome].
    Inui A
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current pharmacotherapy options for cancer anorexia and cachexia.
    Macciò A; Madeddu C; Mantovani G
    Expert Opin Pharmacother; 2012 Dec; 13(17):2453-72. PubMed ID: 23072481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.